Literature DB >> 7142145

Action of viscumin, a toxic lectin from mistletoe, on cells in culture.

F Stirpe, K Sandvig, S Olsnes, A Pihl.   

Abstract

A toxin from mistletoe, viscumin, inhibited the incorporation of leucine in cells more rapidly than the incorporation of uridine and thymidine, indicating that the toxins act by inhibiting cellular protein synthesis. The presence of galactose, lactose, and melibiose in the medium protected cells against viscumin. The sensitivity to viscumin of different cell lines differed considerably. The cytotoxic properties of viscumin were compared to those of the related toxins abrin, ricin, and modeccin. The profile of the sensitivity of a panel of cell lines to viscumin was dissimilar from those obtained with abrin and modeccin. Cell lines selected for resistance to modeccin and ricin were fully sensitive to viscumin. Ca2+ was required for viscumin to express its toxic effect. In contrast, the Ca2+ ionophore A23187 protected the cells against viscumin. Whereas the sensitivity of cells to viscumin did not vary much between pH 7 and 9, the cells were much less sensitive at pH 6. Also, cells treated with the two metabolic inhibitors, 2-deoxyglucose and NaN3, were insensitive to the toxins. Viscumin taken up by cells in the absence of Ca2+ or at pH 6 was able to intoxicate the cells when Ca2+ was added or when the pH was adjusted to neutrality. In contrast, cells exposed to viscumin in the presence of 2-deoxyglucose and NaN3, which inhibit endocytosis, were not intoxicated when the cells were treated with antiviscumin and then transferred to normal medium. The results indicate that endocytosis is involved in the entry of viscumin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways.

Authors:  P W Swaan
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 2.  Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-05       Impact factor: 8.262

3.  Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells.

Authors:  G Ribéreau-Gayon; M L Jung; S Baudino; G Sallé; J P Beck
Journal:  Experientia       Date:  1986-06-15

Review 4.  Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytosol.

Authors:  S Olsnes; B van Deurs; K Sandvig
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

5.  Entry of Shigella dysenteriae toxin into HeLa cells.

Authors:  K Eiklid; S Olsnes
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

Review 6.  Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.

Authors:  Gunver S Kienle; Renate Grugel; Helmut Kiene
Journal:  BMC Complement Altern Med       Date:  2011-08-28       Impact factor: 3.659

Review 7.  Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.

Authors:  Gunver S Kienle; Anja Glockmann; Michael Schink; Helmut Kiene
Journal:  J Exp Clin Cancer Res       Date:  2009-06-11

8.  Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.

Authors:  Oliver Podlech; Patrick N Harter; Michel Mittelbronn; Simone Pöschel; Ulrike Naumann
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-22       Impact factor: 2.629

9.  Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH.

Authors:  I H Madshus; S Olsnes; K Sandvig
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.

Authors:  Susann Kleinsimon; Enya Longmuss; Jana Rolff; Sebastian Jäger; Angelika Eggert; Catharina Delebinski; Georg Seifert
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.